MEI Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $20.51 Millions, with shareholders equity totaling $19.54 Millions.
The company employs approximately 76 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, MEI Pharma Inc. reported $- in revenue, generating net income of $-21.27 Millions.
Key financial metrics include a P/E ratio of -0.96, a price-to-book (P/B) ratio of 1.05, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker MEIP.